Developmental Research Program

认识到发展研究基金是孢子不可分割的一部分，我们承诺每 为这些努力奋斗一年。这在UM前列腺孢子和UM的预算中占了相当大的百分比 反映了该计划对创新翻译研究发展的持续承诺 前列腺癌。发展研究计划(DRP)的重点是为研究人员提供 为提交R01拨款申请或同等建议书生成初步数据的资源 来自前列腺癌领域以外的研究人员被鼓励在校园范围内申请 公告以及通过与孢子调查人员的个人互动。我们开发了一种 使用NIH类型的PHS 398格式的试点项目的逐步建议征求和审查过程，该格式具有 简化了研究提案的快速周转，并认识到这些项目可能已经 几乎没有初步数据。调查人员可以申请试点项目补助金(每人40,000-50,000美元)或种子补助金 (每个5,000-10,000美元)。此外，我们还为暑期学生项目预留了资金(每人5000美元)。自1995年以来， 我们已经在我们的DRP中投资了350万美元，通过68个试点项目、63个种子项目总共资助了83名调查人员 助学金和35个暑期学生项目。这些奖项带来了超过3200万美元的后续孢子 和非孢子同行评审基金和127份已发表的手稿。在当前的赠款周期中，我们 资助51个项目：16个试点项目(每个项目50000美元)、4个种子补助金(每个项目10000美元)和35个暑期学生项目 (每个5000美元)。马哈·侯赛因博士和马克·戴博士担任DRP的联席主任。侯赛因博士是一位 内科和泌尿外科，因其在前列腺方面的临床研究专长而在国际上获得认可 癌症。侯赛因博士参与了肿瘤学培训基金。她是一名

Recognizing that developmental research funds are an integral part of the SPORE, we commit $205,000 per year to these endeavors. This represents a significant percent in the budget of the UM Prostate SPORE and reflects the continued commitment of this program to the development of innovative translational research in prostate cancer. The focus of the Developmental Research Program (DRP) is to provide investigators the resources to generate preliminary data for the submission of an R01 grant application or an equivalent proposal Investigators from outside the field of prostate cancer are encouraged to apply through campus-wide announcements as well as through personal interactions with the SPORE investigators. We developed a stepwise proposal solicitation and review process for pilot projects utilizing an NIH-type PHS 398 format that has been streamlined for rapid turnaround of research proposals and which recognizes that these projects may have little preliminary data. Investigators may apply for pilot project grants ($40,000 - $50,000 each) or seed grants ($5,000 - $10,000 each). In addition, we set aside funds for summer student projects ($5,000 each). Since 1995, we have invested $3.5 million in our DRP, funding a total of 83 investigators though 68 pilot projects, 63 seed grants and 35 summer student projects. These awards have led to over $32 million in subsequent SPORE and non-SPORE peer-reviewed funding and 127 published manuscripts. During this current grant cycle, we funded 51 projects: 16 pilot projects ($50K each), 4 seed grants ($10K each) and 35 summer student projects ($5K each). Drs. Maha Hussain and Mark Day serve as co-Directors for the DRP. Dr. Hussain is a Professor of Internal Medicine and Urology and is internationally recognized for her clinical research expertise in prostate cancer. Dr. Hussain participates with the Oncology Training Grant. She serves as the